Kidney Disease News and Research

RSS

Today’s “World Kidney Day” promotes kidney health for all

Recent surveys have shown that the general public’s understanding about what our kidneys do and what the risk factors for kidney disease are, is astoundingly poor. In the UK, five leading kidney charities are joining forces in the campaign “Kidney Charities Together,” which calls for urgent action to be taken to raise awareness of kidney disease.

12 Mar 2015

Ember Therapeutics, Mariel Therapeutics sign definitive merger agreement

Ember Therapeutics, Inc., a Boston-based biotechnology company dedicated to the discovery and development of novel obesity and diabetic related therapies, and Mariel Therapeutics, a privately held, New York-based biotechnology company developing targeted therapies for osteoarthritis and kidney fibrosis using Bone Morphogenetic Protein (BMP)-7, jointly announce today that they have entered into a definitive agreement to merge the two companies.

12 Mar 2015

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

CTI BioPharma Corp. and Baxter International Inc. today announced positive top-line results for the primary endpoint from PERSIST-1, the randomized, controlled Phase 3 registration clinical trial examining pacritinib, a next generation oral JAK2/FLT3 multikinase inhibitor, for the treatment of patients with primary or secondary myelofibrosis.

From Baxter International Inc. 9 Mar 2015

1 in 5 of the UK population could be walking around with ‘ticking time bomb’

Kidney Research UK polled 2,000 adults across the UK to find out just how much people know about the disease. Startlingly, almost three quarters (74%) of those polled claim to have limited or no knowledge of kidney disease, its causes or its symptoms.

6 Mar 2015

Severe mortality-associated diseases less prevalent in members of long-lived families

Recent research from the Long Life Family Study (LLFS) confirms that severe mortality-associated diseases are less prevalent in the families of long-lived individuals than in the general population. The Journals of Gerontology, Series A will publish these findings in the article titled, "Are Members of Long-Lived Families Healthier than Their Equally Long-Lived Peers? Evidence from the Long Life Family Study" on March 5, 2015.

6 Mar 2015

Resverlogix, Emerald Logic complete collaborative research program

Resverlogix Corp. today announced that it has completed a collaborative research program with Emerald Logic, a leader in quantitative analytics. Using Fast Collective Evolution Technology (FACET), Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Company's Phase 2 clinical trials ASSERT, SUSTAIN and ASSURE.

4 Mar 2015

CCO wants men and women in Ontario to get screened for colorectal cancer

March is Colorectal Cancer Awareness Month, and Cancer Care Ontario wants men and women to start thinking about getting screened.

4 Mar 2015

New report: Prevalence of CKD in the U.S. projected to increase 16.7% by 2030

The prevalence of chronic kidney disease (CKD) will rise in the United States, according to a new report led by RTI International and published in the American Journal of Kidney Diseases during March's National Kidney Month.

3 Mar 2015

EMA's CHMP backs JINARC (tolvaptan) for autosomal dominant polycystic kidney disease

Otsuka Pharmaceutical Co., Ltd. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended JINARC (tolvaptan) for approval.

3 Mar 2015

Cancer Care Ontario raises awareness about colorectal cancer

March is Colorectal Cancer Awareness Month and Cancer Care Ontario (CCO) is on a mission to raise awareness about an organ that doesn't get the attention it deserves.

2 Mar 2015

New medical device could revolutionise kidney disease care in the UK

A new medical device which combines nanotechnology with a pregnancy tester could help diagnose and treat the 1 million people in the UK who don’t know they have kidney disease, a new report by the Institution of Mechanical Engineers reveals today.

26 Feb 2015

Diets high in animal proteins can worsen progression of kidney disease

An estimated 26 million people in the United States have chronic kidney disease, which can lead to complete kidney failure. Once the kidneys fail, patients either need to undergo dialysis treatments three times a week or have a kidney transplant to remain alive.

24 Feb 2015

Regulus Therapeutics reports net loss of $22.2 million for fourth quarter 2014

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and year ended December 31, 2014, including a summary of recent corporate highlights.

19 Feb 2015

Elsevier chosen to publish ISN's Kidney International and Kidney International Supplements journals

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the International Society of Nephrology, the global medical society devoted to advancing kidney care worldwide, announced today that Elsevier will publish ISN's flagship journals, Kidney International and Kidney International Supplements, as of January 1, 2016.

18 Feb 2015

Elsevier to publish ISN's flagship journals, Kidney International and Kidney International Supplements

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the International Society of Nephrology (ISN), the global medical society devoted to advancing kidney care worldwide, announced today that Elsevier will publish ISN's flagship journals, Kidney International and Kidney International Supplements, as of January 1, 2016.

17 Feb 2015

Astute Medical previews upcoming AKI & CRRT 2015 conference to be held in San Diego

Astute Medical, Inc., developer of the NephroCheck® Test, today previewed the upcoming AKI & CRRT 2015 conference to be held in San Diego from February 17 to February 20.

13 Feb 2015

Regulus Therapeutics reports top-line results from RG-101 clinical study for HCV treatment

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").

9 Feb 2015

Artificial mini-organism: An alternative to animal testing

No one wishes to dispense with the blessings of modern medicine, which took away the dread of many diseases. The flipside of the coin: To ensure that effective and safe medications are available, experiments on animals in research laboratories are indispensable.

9 Feb 2015

Women’s risk factors for heart disease

Heart disease is often thought of as a health problem for men, but more and more women die of heart disease each year than men, and from any other disease including breast cancer.

4 Feb 2015

Study shows changes in kidney function among sugarcane workers in northwestern Nicaragua

Sugarcane workers in northwestern Nicaragua experienced a decline in kidney function during the harvest, with field workers at greatest risk, suggesting that heat stress or other occupational factors may be playing a role in the high rates of chronic kidney disease in the region, a new study led by Boston University School of Public Health researchers shows.

3 Feb 2015